Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Henry Schein ( (HSIC) ) has issued an announcement.
On January 29, 2025, Henry Schein, Inc. announced a strategic partnership with KKR, resulting in a $250 million investment in Henry Schein’s common stock, making KKR a 12% shareholder. This collaboration aims to enhance shareholder value through strategic growth and operational excellence. Additionally, the agreement includes board appointments of KKR representatives, Max Lin and William Daniel, and separate board additions, all expected to reinforce Henry Schein’s strategic and financial expertise. The company also shared preliminary financial results for 2024, highlighting a revenue of $12.7 billion and the introduction of financial guidance for 2025, predicting modest growth.
More about Henry Schein
Henry Schein, Inc., headquartered in Melville, New York, is the world’s largest provider of health care solutions, primarily serving office-based dental and medical practitioners.
YTD Price Performance: 11.01%
Average Trading Volume: 1,528,851
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $9.49B
Find detailed analytics on HSIC stock on TipRanks’ Stock Analysis page.
